All results
25 results for randomized double blind placebo controlled study erlotinib or placebo patients
-
Clinical Trials
A prospective, randomized, double-blind, placebo controlled, multi-center therapeutic study for patients age 3 and older with confirmed diagnosis of Niemann…
-
Clinical Trials
This is a multi-center, multi-period study with an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period evaluating…
-
News, Stories & Blog
The University of Florida College of Nursing has received $670,000 from the National Institute of Nursing Research to create an interdisciplinary Biobehavioral…
-
Clinical Trials
This is a Phase 2, multicenter, multinational, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, pharmacokinetics (PK),…
-
News, Stories & Blog
Innovative coronavirus research underway at UF Health Jacksonville Emergency medicine physicians at the University of Florida College of Medicine –…
-
Clinical Trials
This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized…
-
Clinical Trials
To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic…
-
Clinical Trials
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute…
-
News, Stories & Blog
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study…
-
Clinical Trials
The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52…